Summary

The Pharmaceutical Contract Manufacturing Market is valued at USD 99 billion in 2024 growing at a CAGR of 4.3% during the forecast period 2024-2035.

In the rapidly evolving pharmaceutical landscape, small molecule drugs continue to play a pivotal role in shaping innovation and development. Currently, small molecules account for 90% of all pharmaceutical drugs, even as biologics have gained more attention in recent years due to their ability to address a wide range of disorders. The sector has also seen a resurgence in the approval of novel small molecule drugs, with over 50 candidates receiving approval from the US FDA in 2020 alone. This trend has significantly boosted the demand for services provided by pharmaceutical contract research organizations (CROs).
It is important to note that the manufacturing of these novel drug candidates necessitates specialized facilities, advanced equipment, and operational expertise. Consequently, pharmaceutical companies may face challenges in conducting development and manufacturing operations independently. Additionally, the time and cost associated with establishing or acquiring manufacturing capabilities have driven both small and large pharmaceutical companies to increasingly outsource their manufacturing operations to contract manufacturing organizations (CMOs) and contract development and manufacturing organizations (CDMOs). The pressing need for safer and more effective drugs has further heightened the demand for contract manufacturing services.
Influenced by the desire for improved efficiency, traceability, and cost-effectiveness, pharmaceutical contract manufacturing is undergoing significant technological advancements. Outsourcing manufacturing operations to CMOs and CDMOs involves implementing specialized solutions to optimize production workflows, ensure regulatory compliance, and uphold product quality standards. Moreover, there is a growing focus on personalized medicine, which requires flexible manufacturing capabilities to cater to diverse patient needs. As pharmaceutical companies adapt to these evolving dynamics, the demand for advanced solutions tailored to the specific requirements of contract manufacturing services is anticipated to increase in the coming years.


Key Market Segments
Type of Product Manufactured
 API & Intermediates
 FDF
Type of API
 Originator API
 Generic API
API Potency
 Low Potent API
 High Potent API
Type of FDF
 Originator FDF
 Generic FDF
Dosage Form
 Oral Solids
 Liquids
 Emulsions
 Other Dosage Forms
Type of Packaging Offered
 Bottles
 Blisters
 Parenteral
 Others
Scale of Operation
 Small Companies
 Mid-sized Companies
 Large and Very Large Companies
Type of End-user
 Oral Solids
 Liquids
 Emulsions
 Other Dosage Forms
Key Geographical Regions
 North America
 Europe
 Asia-Pacific
 Latin America
 Middle East and North Africa
Research Coverage:
 This report provides a comprehensive look at pharmaceutical packaging, including various types and their features, as well as sustainable packaging options. It also explores the regulatory framework, benefits, and challenges of sustainable packaging, emphasizing the need for adoption and highlighting future perspectives and opportunities.
 A general overview of contract manufacturing services, highlighting details on different types of third-party manufacturers. It also features evolution of global pharmaceutical contract manufacturing market. Further, it provides information on the recent CDMO trends, along the opportunities and future perspectives.
 A detailed discussion on various guidelines laid down by major regulatory bodies, across different countries, featuring an elaborative assessment of over 420 CMOs in pharmaceutical contract manufacturing industry, along with information on their operational approvals, certifications received, and relative popularity of the key regulatory body. Additionally, the chapter features an insightful multi-dimensional bubble analysis, presenting a comparison of the current regulatory scenario in key geographies.
 An overview of the current market landscape of companies engaged in offering contract manufacturing services for small molecules, including a detailed analysis based on several relevant parameters, such as year of establishment, company size (based on number of employees), location of headquarters, location of manufacturing facility, type of manufacturer (CDMO and CMO), product manufacturing capability (API & Intermediates and FDF), type of services offered (pre-formulation development, formulation development, method / analytical / process / assay development, scale-up, fill-finish / packaging and labelling and regulatory support), type of finished dosage form manufactured (oral solid, liquids, emulsions and lyophilized products), type of packaging offered (blister packaging, tubes, vials / cartridges, ampoules, sachets / pouches / bags, inhalers / nasal sprays, glass / plastic bottles / dropper bottles and prefilled syringes / autoinjectors / pen injectors) and scale of operation (preclinical, clinical and commercial).
 A detailed regional capability of pharmaceutical contract manufacturing facilities in different regions (North America, Europe, Asia-Pacific and Rest of the World) across the globe.
 Elaborate profiles of key contract manufacturers in the pharmaceutical contract manufacturing market. Each profile features a brief overview of the pharmaceutical contract manufacturing companies, along with information on location of headquarters, year of establishment, number of employees, leadership team, manufacturing portfolio, financial information, recent developments, and an informed future outlook.
 A brief description of companies in pharmaceutical contract manufacturing. Each profile features a brief description of the company overview, along with information on the manufacturing portfolio.
 A qualitative analysis highlighting various factors that need to be taken into consideration by pharmaceutical drug developers, while deciding whether to manufacture their respective products in-house or engage the services of a CMO.
 A detailed analysis of the various mergers and acquisitions in this domain since 2017, based on several relevant parameters, such as year of agreement, type of agreement, key value drivers of the deal, most active players (in terms of number of agreements signed) and geographical location of the companies. In addition, the chapter provides information on the financial terms of the deals (if available) in order to enumerate the deal multiples (in terms of annual revenues of the acquired firm (at the time of acquisition) and years of experience in this domain).
 A detailed analysis of acquisitions that have taken place in the pharmaceutical contract manufacturing domain, taking into consideration the historical trend of the activity of players that have acquired other firms since 2017, and offering a means for other industry stakeholders to identify potential acquisition targets. The primary purpose of this analysis was to develop a better understanding of the overall potential and capabilities of companies involved in this domain, that are likely to be acquired in the recent future.
 An estimate of the overall installed capacity for the manufacturing of pharmaceuticals, based on information reported by various industry stakeholders in the public domain, highlighting the distribution of the available capacity, based on size of manufacturer (small, mid-sized, and large and very large) and geography (North America, Europe, Asia-Pacific and Rest of the World).
 An informed estimate of the annual clinical and commercial demand for small molecule drugs, across key geographical regions.
 An in-depth analysis of the factors that can impact the growth of the global pharmaceutical contract manufacturing market. It also features identification and analysis of key drivers, potential restraints, emerging opportunities, and existing challenges.
 A detailed estimate of the current market size and the future growth potential of the pharmaceutical contract manufacturing market over the next decade. Based on multiple parameters, such as likely adoption trends and through reliable secondary and primary validations, we have provided an informed estimate on the market evolution during the forecast period 2024-2035. The report also features the likely distribution of the current and forecasted opportunity within the pharmaceutical contract manufacturing industry. Further, in order to account for future uncertainties and to add robustness to our model, we have provided three forecast scenarios, namely conservative, base, and optimistic scenarios, representing different tracks of the pharmaceutical contract manufacturing market growth.
 Detailed projections of the current and future opportunity for contract manufacturers in the pharmaceutical CMO market across various types of products manufactured, such as API & Intermediates and FDF.
 Detailed projections of the current and future opportunity for contract manufacturers in the pharmaceutical contract manufacturing industry across various types of API, such as generic API and originator API.
 Detailed projections of the current and future opportunity for contract manufacturers in the pharmaceutical contract manufacturing industry across types of API by potency, such as low potent API and high potent API.
 Detailed projections of the current and future opportunity for contract manufacturers in the pharmaceutical contract manufacturing market across various types of FDF, such as generic FDF and originator FDF.
 Detailed projections of the current and future opportunity for contract manufacturers in the pharmaceutical CMO market across different types of dosage form offered, such as oral solids, liquids, emulsions, and other dosage forms.
 Detailed projections of the current and future opportunity for contract manufacturers in the pharmaceutical contract manufacturing market across different type of packaging, such as bottles, blisters, parenteral and others.
 Detailed projections of the current and future opportunity for contract manufacturers in the pharmaceutical contract manufacturing industry across different type of end-users, such as small, mid-sized and large and very large companies.
 Detailed projections of the current and future opportunity for contract manufacturers in the pharmaceutical contract manufacturing market across scales of operation, including clinical and commercial.
 Detailed projections of the current and future opportunity for contract manufacturers in the pharmaceutical contract manufacturing market across key geographical regions, such as North America, Europe, Asia-Pacific, Latin America and Middle East and North Africa.
 Detailed list of the current pharmaceutical contract manufacturing market across leading players.
 A case study highlighting a comparison of the key characteristics of large and small molecule drugs, along with information on the steps involved in their respective manufacturing processes.
Key Benefits of Buying this Report
 The report offers market leaders and newcomers valuable insights into revenue estimations for both the overall market and its sub-segments.
 Stakeholders can utilize the report to enhance their understanding of the competitive landscape, allowing for improved business positioning and more effective go-to-market strategies.
 The report provides stakeholders with a pulse on the Pharmaceutical Contract Manufacturing Market, furnishing them with essential information on significant market drivers, barriers, opportunities, and challenges.
Leading Market Companies
 AMRI Global
 Altasciences
 Cambrex
 Catalent
 DPT Laboratories
 Aenova
 Almac
 Corden Pharma
 Fresenius Kabi
 Glatt
 Hovione
 Recipharm
 Siegfried
 CMIC Group
 Nectar Lifesciences
 Syngene
 WuXi AppTec

ページTOPに戻る

Table of Contents

1. PREFACE
1.1. Introduction
1.2. Market Share Insights
1.3. Key Market Insights
1.4. Report Coverage
1.5. Key Questions Answered
1.6. Chapter Outlines
2. RESEARCH METHODOLOGY
2.1. Chapter Overview
2.2. Research Assumptions
2.2.1. Market Landscape and Market Trends
2.2.2. Market Forecast and Opportunity Analysis
2.2.3. Comparative Analysis
2.3. Database Building
2.3.1. Data Collection
2.3.2. Data Validation
2.3.3. Data Analysis
2.4. Project Methodology
2.4.1. Secondary Research
2.4.1.1. Annual Reports
2.4.1.2. Academic Research Papers
2.4.1.3. Company Websites
2.4.1.4. Investor Presentations
2.4.1.5. Regulatory Filings
2.4.1.6. White Papers
2.4.1.7. Industry Publications
2.4.1.8. Conferences and Seminars
2.4.1.9. Government Portals
2.4.1.10. Media and Press Releases
2.4.1.11. Newsletters
2.4.1.12. Industry Databases
2.4.1.13. Roots Proprietary Databases
2.4.1.14. Paid Databases and Sources
2.4.1.15. Social Media Portals
2.4.1.16. Other Secondary Sources
2.4.2. Primary Research
2.4.2.1. Types of Primary Research
2.4.2.1.1. Qualitative Research
2.4.2.1.2. Quantitative Research
2.4.2.1.3. Hybrid Approach
2.4.2.2. Advantages of Primary Research
2.4.2.3. Techniques for Primary Research
2.4.2.3.1. Interviews
2.4.2.3.2. Surveys
2.4.2.3.3. Focus Groups
2.4.2.3.4. Observational Research
2.4.2.3.5. Social Media Interactions
2.4.2.4. Key Opinion Leaders Considered in Primary Research
2.4.2.4.1. Company Executives (CXOs)
2.4.2.4.2. Board of Directors
2.4.2.4.3. Company Presidents and Vice Presidents
2.4.2.4.4. Research and Development Heads
2.4.2.4.5. Technical Experts
2.4.2.4.6. Subject Matter Experts
2.4.2.4.7. Scientists
2.4.2.4.8. Doctors and Other Healthcare Providers
2.4.2.5. Ethics and Integrity
2.4.2.5.1. Research Ethics
2.4.2.5.2. Data Integrity
2.4.3. Analytical Tools and Databases
3. ECONOMIC AND OTHER PROJECT SPECIFIC CONSIDERATIONS
3.1. Chapter Overview
3.2. Market Dynamics
3.2.1. Time Period
3.2.1.1. Historical Trends
3.2.1.2. Current and Future Estimates
3.2.2. Currency Coverage and Foreign Exchange Rate
3.2.2.1. Major Currencies Affecting the Market
3.2.2.2. Factors Affecting Currency Fluctuations and Foreign Exchange Rate
3.2.2.3. Impact of Foreign Exchange Rate Volatility on the Market
3.2.2.4. Strategies for Mitigating Foreign Exchange Risk
3.2.3. Trade Policies
3.2.3.1. Impact of Trade Barriers on the Market
3.2.3.2. Strategies for Mitigating the Risk Associated with Trade Barriers
3.2.4. Recession
3.2.4.1. Historical Analysis of Past Recessions and Lessons Learnt
3.2.4.2. Assessment of Current Economic Conditions and Potential Impact on the Market
3.2.5. Inflation
3.2.5.1. Measurement and Analysis of Inflationary Pressures in the Economy
3.2.5.2. Potential Impact of Inflation on the Market Evolution
4. EXECUTIVE SUMMARY
5. INTRODUCTION
5.1. Chapter Overview
5.2. Overview of Pharmaceutical Packaging
5.3. Advantages of Pharmaceutical Packaging
5.4. Types of Pharmaceutical Packaging
5.5. Need for Sustainable Pharmaceutical Packaging
5.6. Sustainable Pharmaceutical Packaging Solutions
5.7. Regulatory Framework
5.8. Advantages of Sustainable Packaging Materials
5.9. Limitations of Sustainable Packaging Materials
5.10. Future Perspectives
6. MARKET LANDSCAPE
6.1. Chapter Overview
6.2. Sustainable Packaging Providers: Overall Market Landscape
6.2.1. Analysis by Year of Establishment
6.2.2. Analysis by Company Size
6.2.3. Analysis by Location of Headquarters (Region)
6.2.4. Analysis by Location of Headquarters (Country)
6.2.5. Analysis by Company Size and Location of Headquarters (Region)
6.2.6. Analysis by Type of Offering
6.2.7. Analysis by ISO Certifications / Accreditations
6.2.8. Analysis by Type of Packaging
6.2.9. Analysis by Location of Headquarters (Region) and Type of Packaging
6.2.10. Analysis by Type of Eco-friendly Packaging
6.2.11. Analysis by Location of Headquarters (Region) and Type of Eco-friendly Packaging
6.2.12. Analysis by Origin of Packaging Material
6.2.13. Analysis by Type of Packaging Material Used
6.2.14. Analysis by Packaging Applications
6.2.15. Most Active Players: Distribution by Number of Packaging Products Offered
7. DETAILED COMPANY PROFILES
7.1. Chapter Overview
7.2. Drug Plastics
7.2.1. Company Overview
7.2.2. Sustainable Packaging Offerings
7.2.3. Recent Developments and Future Outlook
7.3. DS SMITH
7.3.1. Company Overview
7.3.2. Financial Information
7.3.3. Sustainable Packaging Offerings
7.3.4. Recent Developments and Future Outlook
7.4. MM Board & Paper
7.4.1. Company Overview
7.4.2. Financial Information
7.4.3. Sustainable Packaging Offerings
7.4.4. Recent Developments and Future Outlook
7.5. Mondi
7.5.1. Company Overview
7.5.2. Financial Information
7.5.3. Sustainable Packaging Offerings
7.5.4. Recent Developments and Future Outlook
7.6. PGP GLASS
7.6.1. Company Overview
7.6.2. Financial Information
7.6.3. Sustainable Packaging Offerings
7.6.4. Recent Developments and Future Outlook
7.7. Smurfit Kappa
7.7.1. Company Overview
7.7.2. Financial Information
7.7.3. Sustainable Packaging Offerings
7.7.4. Recent Developments and Future Outlook
7.8. Syntegon
7.8.1. Company Overview
7.8.2. Sustainable Packaging Offerings
7.8.3. Recent Developments and Future Outlook
7.9. Berry Global
7.9.1. Company Overview
7.9.2. Financial Information
7.9.3. Sustainable Packaging Offerings
7.9.4. Recent Developments and Future Outlook
7.10. Huhtamaki
7.10.1. Company Overview
7.10.2. Financial Information
7.10.3. Sustainable Packaging Offerings
7.10.4. Recent Developments and Future Outlook
7.11. SGD Pharma
7.11.1. Company Overview
7.11.2. Sustainable Packaging Offerings
7.11.3. Recent Developments and Future Outlook
8. SHORT COMPANY PROFILES
8.1. Chapter Overview
8.2. Amcor
8.2.1. Company Overview
8.2.2. Sustainable Packaging Offerings
8.3. Bormioli Pharma
8.3.1. Company Overview
8.3.2. Sustainable Packaging Offerings
8.4. EPL
8.4.1. Company Overview
8.4.2. Sustainable Packaging Offerings
8.5. Gerresheimer
8.5.1. Company Overview
8.5.2. Sustainable Packaging Offerings
8.6. Greiner Packaging
8.6.1. Company Overview
8.6.2. Sustainable Packaging Offerings
8.7. International Paper
8.7.1. Company Overview
8.7.2. Sustainable Packaging Offerings
8.8. PPC Flexible Packaging
8.8.1. Company Overview
8.8.2. Sustainable Packaging Offerings
8.9. Stoelzle Glass
8.9.1. Company Overview
8.9.2. Sustainable Packaging Offerings
8.10. Takemoto Packaging
8.10.1. Company Overview
8.10.2. Sustainable Packaging Offerings
8.11. Tekni-Plex
8.11.1. Company Overview
8.11.2. Sustainable Packaging Offerings
9. COMPANY COMPETITIVENESS ANALYSIS
9.1. Chapter Overview
9.2. Assumptions and Key Parameters
9.3. Methodology
9.4. Sustainable Packaging Providers: Company Competitiveness Analysis
9.4.1. Sustainable Packaging Providers Based in North America
9.4.2. Sustainable Packaging Providers Based in Europe
9.4.3. Sustainable Packaging Providers Based in Asia-Pacific
10. PARTNERSHIPS AND COLLABORATIONS
10.1. Chapter Overview
10.2. Partnership Models
10.3. Sustainable Packaging Providers: Partnerships and Collaborations
10.3.1. Analysis by Year of Partnership
10.3.2. Analysis by Type of Partnership
10.3.3. Analysis by Year and Type of Partnership
10.3.4. Analysis by Type of Partner
10.3.5. Analysis by Type of Eco-friendly Packaging
10.3.6. Most Active Players: Analysis by Number of Partnerships
10.3.7. Analysis by Geography
10.3.7.1. Local and International Agreements
10.3.7.2. Intracontinental and Intercontinental Agreements
11. FUNDING AND INVESTMENTS
11.1. Chapter Overview
11.2. Funding Models
11.3. Sustainable Packaging Providers: Funding and Investments
11.3.1. Analysis by Year of Funding
11.3.2. Analysis by Type of Funding
11.3.3. Analysis by Year and Type of Funding
11.3.4. Analysis by Amount Invested
11.3.5. Analysis by Type of Funding and Amount Invested
11.3.6. Analysis by Geography
11.3.7. Most Active Players: Analysis by Number of Funding Instances
11.3.8. Most Active Players: Analysis by Amount Raised
11.3.9. Leading Investors: Analysis by Number of Funding Instances
11.4. Concluding Remarks
12. MARKET IMPACT ANALYSIS: DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES
12.1. Chapter Overview
12.2. Market Drivers
12.3. Market Restraints
12.4. Market Opportunities
12.5. Market Challenges
12.6. Conclusion
13. DEMAND ANALYSIS
13.1. Chapter Overview
13.2. Key Assumptions and Methodology
13.3. Global Demand for Sustainable Packaging in Healthcare Industry, Historical Trends (2019-2023) and Forecasted Estimates (2024-2035)
13.3.1. Analysis by Type of Packaging
13.3.2. Analysis by Type of Packaging Containers
13.3.2.1. Analysis by Primary Packaging Containers
13.3.2.2. Analysis by Secondary Packaging Containers
13.3.2.3. Analysis by Tertiary Packaging Containers
14. GLOBAL SUSTAINABLE PACKAGING MARKET
14.1. Chapter Overview
14.2. Key Assumptions and Methodology
14.3. Global Sustainable Packaging Market, Historical Trends (2019-2023) and Forecasted Estimates (2024-2035)
14.3.1. Scenario Analysis
14.3.1.1. Conservative Scenario
14.3.1.2. Optimistic Scenario
14.4. Key Market Segmentations
15. SUSTAINABLE PACKAGING MARKET, BY TYPE OF ECO-FRIENDLY PACKAGING
15.1. Chapter Overview
15.2. Key Assumptions and Methodology
15.3. Sustainable Packaging Market: Distribution by Eco-friendly Packaging, 2024, 2028 and 2035
15.3.1. Sustainable Packaging Market for Recyclable / Reusable Packaging, Historical Trends (2019-2023) and Forecasted Estimates (2024-2035)
15.3.2. Sustainable Packaging Market for Biodegradable Packaging, Historical Trends (2019-2023) and Forecasted Estimates (2024-2035)
15.4. Data Triangulation and Validation
16. SUSTAINABLE PACKAGING MARKET, BY TYPE OF PACKAGING
16.1. Chapter Overview
16.2. Key Assumptions and Methodology
16.3. Sustainable Packaging Market: Distribution by Type of Packaging, 2024, 2028 and 2035
16.3.1. Sustainable Packaging Market for Primary Packaging, Historical Trends (2019-2023) and Forecasted Estimates (2024-2035)
16.3.2. Sustainable Packaging Market for Secondary Packaging, Historical Trends (2019-2023) and Forecasted Estimates (2024-2035)
16.3.3. Sustainable Packaging Market for Tertiary Packaging, Historical Trends (2019-2023) and Forecasted Estimates (2024-2035)
16.4. Data Triangulation and Validation
17. SUSTAINABLE PACKAGING MARKET, BY TYPE OF PACKAGING CONTAINER
17.1. Chapter Overview
17.2. Key Assumptions and Methodology
17.3. Sustainable Packaging Market for Primary Packaging Containers
17.3.1. Sustainable Packaging Market: Distribution by Primary Packaging Containers, 2024, 2028 and 2035
17.3.1.1. Sustainable Packaging Market for Vials, Historical Trends (2019-2023) and Forecasted Estimates (2024-2035)
17.3.1.2. Sustainable Packaging Market for Ampoules, Historical Trends (2019-2023) and Forecasted Estimates (2024-2035)
17.3.1.3. Sustainable Packaging Market for Bottles, Historical Trends (2019-2023) and Forecasted Estimates (2024-2035)
17.3.1.4. Sustainable Packaging Market for Syringes, Historical Trends (2019-2023) and Forecasted Estimates (2024-2035)
17.3.1.5. Sustainable Packaging Market for Cartridges, Historical Trends (2019-2023) and Forecasted Estimates (2024-2035)
17.4. Sustainable Packaging Market for Secondary Packaging Containers
17.4.1. Sustainable Packaging Market: Distribution by Secondary Packaging Containers, 2024, 2028 and 2035
17.4.1.1. Sustainable Packaging Market for Boxes / Cartons, Historical Trends (2019-2023) and Forecasted Estimates (2024-2035)
17.4.1.2. Sustainable Packaging Market for Pouches, Historical Trends (2019-2023) and Forecasted Estimates (2024-2035)
17.5. Sustainable Packaging Market for Tertiary Packaging Containers
17.5.1. Sustainable Packaging Market: Distribution by Tertiary Packaging Containers, 2024, 2028 and 2035
17.5.1.1. Sustainable Packaging Market for Boxes, Historical Trends (2019-2023) and Forecasted Estimates (2024-2035)
17.5.1.2. Sustainable Packaging Market for Cartons, Historical Trends (2019-2023) and Forecasted Estimates (2024-2035)
17.5.1.3. Sustainable Packaging Market for Shippers, Historical Trends (2019-2023) and Forecasted Estimates (2024-2035)
17.6. Data Triangulation and Validation
18. SUSTAINABLE PACKAGING MARKET, BY END-USERS
18.1. Chapter Overview
18.2. Key Assumptions and Methodology
18.3. Sustainable Packaging Market: Distribution by End-users, 2024, 2028 and 2035
18.3.1. Sustainable Packaging Market for Pharmaceutical and Biotechnology Companies, Historical Trends (2019-2023) and Forecasted Estimates (2024-2035)
18.3.2. Sustainable Packaging Market for Research Institutes, Historical Trends (2019-2023) and Forecasted Estimates (2024-2035)
18.3.2. Sustainable Packaging Market for Other Users, Historical Trends (2019-2023) and Forecasted Estimates (2024-2035)
18.4. Data Triangulation and Validation
19. SUSTAINABLE PACKAGING MARKET, BY KEY GEOGRAPHICAL REGIONS
19.1. Chapter Overview
19.2. Key Assumptions and Methodology
19.3. Sustainable Packaging Market: Distribution by Key Geographical Regions, 2024, 2028 and 2035
19.3.1. Sustainable Packaging Market in North America, Historical Trends (2019-2023) and Forecasted Estimates (2024-2035)
19.3.2. Sustainable Packaging Market in Europe, Historical Trends (2019-2023) and Forecasted Estimates (2024-2035)
19.3.3. Sustainable Packaging Market in Asia-Pacific, Historical Trends (2019-2023) and Forecasted Estimates (2024-2035)
19.3.4. Sustainable Packaging Market in Middle East and North Africa, Historical Trends (2019-2023) and Forecasted Estimates (2024-2035)
19.3.5. Sustainable Packaging Market in Latin America, Historical Trends (2019-2023) and Forecasted Estimates (2024-2035)
19.3.5. Sustainable Packaging Market in Rest of the World, Historical Trends (2019-2023) and Forecasted Estimates (2024-2035)
19.4. Data Triangulation and Validation
20. CONCLUSION
21. EXECUTIVE INSIGHTS
21.1. Chapter Overview
21.2. Packaging Guru
21.2.1. Company Snapshot
21.2.2. Interview Transcript
21.3. eutecma
21.3.1. Company Snapshot
21.3.2. Interview Transcript
21.4. SOFTBOX SYSTEMS
21.4.1. Company Snapshot
21.4.2. Interview Transcript
21.5. Coveris
21.5.1. Company Snapshot
21.5.2. Interview Transcript
21.6. KÖRBER
21.6.1. Company Snapshot
21.6.2. Interview Transcript
21.7. Bormioli Pharma
21.7.1. Company Snapshot
21.7.2. Interview Transcript
21.8. A Finland-Based Large Company
21.8.1. Interview Transcript
22. APPENDIX 1: TABULATED DATA
23. APPENDIX 2: LIST OF COMPANIES AND ORGANIZATIONS

ページTOPに戻る

List of Tables/Graphs

Table 6.1 Sustainable Packaging Providers: Information on Year of Establishment, Company Size and Location of Headquarters
Table 6.2 Sustainable Packaging Providers: Information on Type of Offering and ISO Certifications / Accreditations
Table 6.3 Sustainable Packaging Providers: Information on Type of Packaging
Table 6.4 Sustainable Packaging Providers: Information on Type of Eco-friendly Packaging and Technology Used
Table 6.5 Sustainable Packaging Providers: Information on Origin of Packaging Material and Type of Packaging Material Used
Table 6.6 Sustainable Packaging Providers: Information on Dosage Form
Table 6.7 Sustainable Packaging Providers: Information on Packaging Applications
Table 7.1 List of Companies: Detailed Profiles
Table 7.2 Drug Plastics: Company Overview
Table 7.3 Drug Plastics: Sustainable Packaging Offerings
Table 7.4 DS Smith: Company Overview
Table 7.5 DS Smith: Sustainable Packaging Offerings
Table 7.6 MM Board & Paper: Company Overview
Table 7.7 MM Board & Paper: Sustainable Packaging Offerings
Table 7.8 Mondi: Company Overview
Table 7.9 Mondi: Sustainable Packaging Offerings
Table 7.10 Mondi: Recent Developments and Future Outlook
Table 7.11 PGP Glass: Company Overview
Table 7.12 PGP Glass: Sustainable Packaging Offerings
Table 7.13 Smurfit Kappa: Company Overview
Table 7.14 Smurfit Kappa: Sustainable Packaging Offerings
Table 7.15 Smurfit Kappa: Recent Developments and Future Outlook
Table 7.16 Syntegon: Company Overview
Table 7.17 Syntegon: Sustainable Packaging Offerings
Table 7.18 Syntegon: Recent Developments and Future Outlook
Table 7.19 List of Other Companies Profiled
Table 7.20 Berry Global: Company Overview
Table 7.21 Berry Global: Sustainable Packaging Offerings
Table 7.22 Berry Global: Recent Developments and Future Outlook
Table 7.23 Huhtamaki: Company Overview
Table 7.24 Huhtamaki: Sustainable Packaging Offerings
Table 7.25 SGD Pharma: Company Overview
Table 7.26 SGD Pharma: Sustainable Packaging Offerings
Table 7.27 SGD Pharma: Recent Developments and Future Outlook
Table 8.1 List of Companies: Short Profiles
Table 8.2 Amcor: Company Overview
Table 8.3 Amcor: Sustainable Packaging Offerings
Table 8.4 Bormioli Pharma: Company Overview
Table 8.5 Bormioli Pharma: Sustainable Packaging Offerings
Table 8.6 EPL: Company Overview
Table 8.7 EPL: Sustainable Packaging Offerings
Table 8.8 Gerresheimer: Company Overview
Table 8.9 Gerresheimer: Sustainable Packaging Offerings
Table 8.10 Greiner Packaging: Company Overview
Table 8.11 Greiner Packaging: Sustainable Packaging Offerings
Table 8.12 International Paper: Company Overview
Table 8.13 International Paper: Sustainable Packaging Offerings
Table 8.14 PPC Flexible Packaging: Company Overview
Table 8.15 PPC Flexible Packaging: Sustainable Packaging Offerings
Table 8.16 Stoelzle Glass: Company Overview
Table 8.17 Stoelzle Glass: Sustainable Packaging Offerings
Table 8.18 Takemoto Packaging: Company Overview
Table 8.19 Takemoto Packaging: Sustainable Packaging Offerings
Table 8.20 Tekni-Plex: Company Overview
Table 8.21 Tekni-Plex: Sustainable Packaging Offerings
Table 10.1 Sustainable Packaging Providers: List of Partnerships and Collaborations, 2019-2024
Table 10.2 Partnerships and Collaborations: Information on Location of Headquarters (Country and Region) and Type of Agreement (Country and Region)
Table 11.1 Sustainable Packaging Market: List of Funding and Investments, 2019-2024
Table 21.1 Packaging Guru: Company Snapshot
Table 21.2 eutecma: Company Snapshot
Table 21.3 XX: Company Snapshot
Table 21.4 Softbox Systems: Company Snapshot
Table 21.5 Coveris: Company Snapshot
Table 21.6 Körber: Company Snapshot
Table 21.7 Bormioli Pharma: Company Snapshot
Table 22.1 Sustainable Packaging Providers: Distribution by Year of Establishment
Table 22.2 Sustainable Packaging Providers: Distribution by Company Size
Table 22.3 Sustainable Packaging Providers: Distribution by Location of Headquarters (Region)
Table 22.4 Sustainable Packaging Providers: Distribution by Location of Headquarters (Country)
Table 22.5 Sustainable Packaging Providers: Distribution by Company Size and Location of Headquarters (Region)
Table 22.6 Sustainable Packaging Providers: Distribution by Type of Offering
Table 22.7 Sustainable Packaging Providers: Distribution by ISO Certifications / Accreditations
Table 22.8 Sustainable Packaging Providers: Distribution by Type of Packaging
Table 22.9 Sustainable Packaging Providers: Distribution by Location of Headquarters (Region) and Type of Packaging
Table 22.10 Sustainable Packaging Providers: Distribution by Type of Eco-friendly Packaging
Table 22.11 Sustainable Packaging Providers: Distribution by Location of Headquarters (Region) and Type of Eco-friendly Packaging
Table 22.12 Sustainable Packaging Providers: Distribution by Origin of Packaging Material
Table 22.13 Sustainable Packaging Providers: Distribution by Type of Packaging Material Used
Table 22.14 Sustainable Packaging Providers: Distribution by Packaging Applications
Table 22.15 Most Active Players: Distribution by Number of Packaging Products Offered
Table 22.16 DS Smith: Annual Revenues, FY 2019 – H1 FY 2024 (GBP Million)
Table 22.17 MM Board & Paper: Annual Revenues, FY 2019 – FY 2023 (EUR Million)
Table 22.18 Mondi: Annual Revenues, FY 2019 – FY 2023 (EUR Million)
Table 22.19 PGP Glass: Annual Revenues, FY 2022 - FY 2023 (INR Billion)
Table 22.20 Smurfit Kappa: Annual Revenues, FY 2019 – FY 2023 (EUR Million)
Table 22.21 Berry Global: Annual Revenues, FY 2019 – Q1 FY 2024 (USD Million)
Table 22.22 Huhtamaki: Annual Revenues, FY 2019 – FY 2023 (EUR Million)
Table 22.23 Partnerships and Collaborations: Cumulative Year-wise Trend, 2019-2024
Table 22.24 Partnerships and Collaborations: Distribution by Type of Partnership
Table 22.25 Partnerships and Collaborations: Distribution by Year and Type of Partnership, 2019-2024
Table 22.26 Partnerships and Collaborations: Distribution by Type of Partner
Table 22.27 Partnerships and Collaborations: Distribution by Type of Eco-friendly Packaging
Table 22.28 Most Active Players: Distribution by Number of Partnerships
Table 22.29 Partnership and Collaborations: Local and International Agreements
Table 22.30 Partnerships and Collaborations: Intracontinental and Intercontinental Agreements
Table 22.31 Funding and Investments: Cumulative Year-wise Trend, 2019-2024
Table 22.32 Funding and Investments: Distribution of Instances by Type of Funding
Table 22.33 Funding and Investments: Distribution by Year and Type of Funding, 2019-2024
Table 22.34 Funding and Investments: Distribution by Amount Invested, 2020-2024 (USD Million)
Table 22.35 Funding and Investments: Distribution of Type of Funding and Amount Invested (USD Million)
Table 22.36 Funding and Investments: Distribution by Geography (Region)
Table 22.37 Most Active Players: Distribution by Number of Funding Instances
Table 22.38 Most Active Players: Distribution by Amount Raised (USD Million)
Table 22.39 Leading Investors: Distribution by Number of Funding Instances
Table 22.40 Funding and Investments Summary, 2019-2024 (USD Million)
Table 22.41 Global Demand for Sustainable Packaging, till 2035 (Billion Units)
Table 22.42 Global Demand for Sustainable Packaging: Distribution by Type of Packaging, till 2035 (Billion Units)
Table 22.43 Global Sustainable Packaging Demand for Primary Packaging Containers, till 2035 (Billion Units)
Table 22.44 Global Sustainable Packaging Demand for Secondary Packaging Containers, till 2035 (Billion Units)
Table 22.45 Global Sustainable Packaging Demand for Tertiary Packaging Containers, till 2035 (Billion Units)
Table 22.46 Global Sustainable Packaging Market, till 2035 (USD Billion)
Table 22.47 Global Sustainable Packaging Market, Forecasted Estimates (2024-2035): Conservative Scenario (USD Billion)
Table 22.48 Global Sustainable Packaging Market, Forecasted Estimates (2024-2035): Optimistic Scenario (USD Billion)
Table 22.49 Sustainable Packaging Market: Distribution by Type of Eco-friendly Packaging, 2024, 2028 and 2035
Table 22.50 Sustainable Packaging Market for Biodegradable Packaging, till 2035 (USD Billion)
Table 22.51 Sustainable Packaging Market for Recyclable / Reusable Packaging, till 2035, Conservative, Base and Optimistic Scenarios (USD Billion)
Table 22.52 Sustainable Packaging Market: Distribution by Type of Packaging, 2024, 2028 and 2035
Table 22.53 Sustainable Packaging Market for Primary Packaging, till 2035, Conservative, Base and Optimistic Scenarios (USD Billion)
Table 22.54 Sustainable Packaging Market for Secondary Packaging, till 2035, Conservative, Base and Optimistic Scenarios (USD Billion)
Table 22.55 Sustainable Packaging Market for Tertiary Packaging, till 2035, Conservative, Base and Optimistic Scenarios (USD Billion)
Table 22.56 Sustainable Packaging Market: Distribution by Type of Primary Packaging Container, 2024, 2028 and 2035
Table 22.57 Primary Sustainable Packaging Market for Vials, till 2035, Conservative, Base and Optimistic Scenarios (USD Billion)
Table 22.58 Primary Sustainable Packaging Market for Ampoules, till 2035, Conservative, Base and Optimistic Scenarios (USD Billion)
Table 22.59 Primary Sustainable Packaging Market for Bottles, till 2035, Conservative, Base and Optimistic Scenarios (USD Billion)
Table 22.60 Primary Sustainable Packaging Market for Cartridges, till 2035, Conservative, Base and Optimistic Scenarios (USD Billion)
Table 22.61 Primary Sustainable Packaging Market for Syringes, till 2035, Conservative, Base and Optimistic Scenarios (USD Billion)
Table 22.62 Sustainable Packaging Market: Distribution by Type of Secondary Packaging Container, 2024, 2028 and 2035
Table 22.63 Secondary Sustainable Packaging Market for Boxes / Cartons, till 2035, Conservative, Base and Optimistic Scenarios (USD Billion)
Table 22.64 Secondary Sustainable Packaging Market for Pouches, till 2035, Conservative, Base and Optimistic Scenarios (USD Billion)
Table 22.65 Sustainable Packaging Market: Distribution by Type of Tertiary Packaging Container, 2024, 2028 and 2035
Table 22.66 Tertiary Sustainable Packaging Market for Boxes, till 2035, Conservative, Base and Optimistic Scenarios (USD Billion)
Table 22.67 Tertiary Sustainable Packaging Market for Cartons, till 2035, Conservative, Base and Optimistic Scenarios (USD Billion)
Table 22.68 Tertiary Sustainable Packaging Market for Shippers, till 2035, Conservative, Base and Optimistic Scenarios (USD Billion)
Table 22.69 Sustainable Packaging Market: Distribution by End-user, 2024, 2028 and 2035
Table 22.70 Sustainable Packaging Market for Pharmaceutical and Biotechnology Companies, till 2035, Conservative, Base and Optimistic Scenarios (USD Billion)
Table 22.71 Sustainable Packaging Market for Research Institutes, till 2035, Conservative, Base and Optimistic Scenarios (USD Billion)
Table 22.72 Sustainable Packaging Market for Other End-users, till 2035, Conservative, Base and Optimistic Scenarios (USD Billion)
Table 22.73 Sustainable Packaging Market: Distribution by Key Geographical Regions, 2024, 2028 and 2035
Table 22.74 Sustainable Packaging Market in North America, till 2035, Conservative, Base and Optimistic Scenarios (USD Billion)
Table 22.75 Sustainable Packaging Market in Europe, till 2035, Conservative, Base and Optimistic Scenarios (USD Billion)
Table 22.76 Sustainable Packaging Market in Asia-Pacific, till 2035, Conservative, Base and Optimistic Scenarios (USD Billion)
Table 22.77 Sustainable Packaging Market in Middle East and North Africa, till 2035, Conservative, Base and Optimistic Scenarios (USD Billion)
Table 22.78 Sustainable Packaging Market in Latin America, till 2035, Conservative, Base and Optimistic Scenarios (USD Billion)
Table 22.79 Sustainable Packaging Market in Rest of the World, till 2035, Conservative, Base and Optimistic Scenarios (USD Billion)